Lancet. 2016 Apr 11. pii: S0140-6736(15)01317-3. doi: 10.1016/S0140-6736(15)01317-3. [Epub ahead of print] Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial. Burki…

Br J Haematol. 2016 Mar 24. doi: 10.1111/bjh.13992. [Epub ahead of print] A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma. col…